Gwendolyn J. Griffioen

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.

Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.

Journal: International journal of radiation oncology, biology, physics

Published: July 18, 2019

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Journal: Lancet (London, England)

Published: June 21, 2018

High-dose conventional thoracic re-irradiation for lung cancer: updated results.

High-dose conventional thoracic re-irradiation for lung cancer: updated results.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 30, 2015

Second primary lung cancers following a diagnosis of primary head and neck cancer.

Second primary lung cancers following a diagnosis of primary head and neck cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 25, 2014

A brief report on outcomes of stereotactic ablative radiotherapy for a second primary lung cancer: evidence in support of routine CT surveillance.

A brief report on outcomes of stereotactic ablative radiotherapy for a second primary lung cancer: evidence in support of routine CT surveillance.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: August 27, 2014

High-dose, conventionally fractionated thoracic reirradiation for lung tumors.

High-dose, conventionally fractionated thoracic reirradiation for lung tumors.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 23, 2013

Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.

Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 10, 2013

Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery.

Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 18, 2013

Bowel-sparing intensity-modulated radiotherapy (IMRT) for palliation of large-volume pelvic bone metastases: rationale, technique and clinical implementation.

Bowel-sparing intensity-modulated radiotherapy (IMRT) for palliation of large-volume pelvic bone metastases: rationale, technique and clinical implementation.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 13, 2012

Comparing rigid and deformable dose registration for high dose thoracic re-irradiation.

Comparing rigid and deformable dose registration for high dose thoracic re-irradiation.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: September 04, 2012

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.

Journal: BMC cancer

Published: April 18, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026